Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the research is to determine if patients have fewer Heart Failure (HF) events
after receiving Aquapheresis (AQ) therapy compared to intravenous (IV) diuretics up to 90
days of discharge from the hospital. Heart Failure events are defined as returning to the
hospital, clinic or emergency department (ED) for treatment of HF symptoms.